跳转至内容
Merck
  • Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells.

Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells.

Oncology reports (2014-11-15)
Xiaojun Liu, Zhongxia Yang, Zhaofeng Chen, Rui Chen, Da Zhao, Yongning Zhou, Liang Qiao
摘要

Lactate dehydrogenase A (LDH-A), which regulates glycolytic flux by catalyzing pyruvate to lactate in the cytoplasm, is believed to be one of the highly attractive therapeutic targets for cancers. Firstly, we detected the expression of LDH-A in gastric cancer (GC) cells. LDH-A inhibitor oxamate was then used to suppress the LDH-A activity in GC cells. Cell proliferation, lactic acid production, Transwell migration assay and apoptosis were assessed, respectively. The results showed that inhibition of LDH-A by oxamate decreased the lactate production. In the presence of glucose, oxamate inhibited cell proliferation in a dose-dependent manner. Flow cytometry assay further confirmed a pro-apoptotic effect of oxamate, and this was likely through increased expression of Bax, activated caspase-3, and decreased expression of Bcl-2. Therefore, we believe that oxamate inhibits cell growth, suppresses tumor invasion, and induces apoptosis in GC cells. LDH-A may be a potential therapeutic target for GC.

材料
货号
品牌
产品描述

Sigma-Aldrich
碘化丙啶, ≥94.0% (HPLC)
Sigma-Aldrich
苯甲磺酰氟, ≥98.5% (GC)
Sigma-Aldrich
D -(+)-半乳糖, ≥99% (HPLC), BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
苯甲磺酰氟, ≥99.0% (T)
USP
Galactose, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
D -(+)-半乳糖, ≥99% (HPLC)
Sigma-Aldrich
碘化丙啶 溶液
Sigma-Aldrich
D -(+)-半乳糖, ≥98% (HPLC)
Sigma-Aldrich
碘化丙啶, ≥94% (HPLC)
Supelco
D -(+)-半乳糖, Pharmaceutical Secondary Standard; Certified Reference Material
Millipore
D -(+)-半乳糖, suitable for microbiology, ≥99.0%
Sigma-Aldrich
D -(+)-半乳糖, BioXtra, ≥99% (HPLC)
Sigma-Aldrich
D -(+)-半乳糖, meets analytical specification of Ph. Eur., BP
D -(+)-半乳糖, European Pharmacopoeia (EP) Reference Standard